To include your compound in the COVID-19 Resource Center, submit it here.

University of Pennsylvania, Novartis deal

The university and the pharma plan to build the Center for Advanced Cellular Therapeutics (CACT) to accelerate

Read the full 178 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE